Pds biotechnology corp PDSB.US Value Analysis
US StockHealth Care
(No presentation for PDSB)
PDSB Value Score
3
24
15
Limited Growth
- AI analysis rates PDSB with a lower value score of 2.
- It is mainly due to unstable operating cash flow, along with potential value may be lower.
- Over the past 3 months, PDSB has maintained a consecutive value rating of 2.0, close to the rating of 1.5 over the past 3 years, indicating low growth opportunities for enterprise value.
- Compared to all stocks in the Health Care sector, PDSB has a medium value rating.
PDSB Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
No related data records
PDSB Financial Forecast
Unit : USD
Update to 2025/5/4 (Quarterly Update)
PDSB Earnings Table
No related data records
PDSB Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
PDSB Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of PDSB from 2015/10 till Now
- -
- Cumulative Return
- -
- Annual Return
- -
- Volatility
- -
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from October, 2015 to May, 2025. (Total Trades: 0)
| PDSB | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | - | 44% | 53% |
| Avg Return | - | 63.1% | 72.3% |
| Avg Profit | - | 198.4% | 166.4% |
| Avg Loss | - | -44.8% | -34.6% |
| Avg Risk-Reward Ratio | - | 442.5% | 480.4% |
Update to 2025/5/8 (Daily Update)